Checkpoint Therapeutics, Inc. - Common Stock (CKPT)
2.8400
0.00 (0.00%)
Checkpoint Therapeutics Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative treatments for cancer
The company specializes in targeted and immune-oncology therapies, aiming to advance new options for patients suffering from various types of solid tumors. Through its research initiatives and clinical trials, Checkpoint Therapeutics seeks to develop therapies that can effectively address unmet medical needs in oncology, leveraging modern scientific advancements to enhance patient outcomes.
Frequently Asked Questions
Is Checkpoint Therapeutics, Inc. - Common Stock publicly traded?
Yes, Checkpoint Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Checkpoint Therapeutics, Inc. - Common Stock trade on?
Checkpoint Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Checkpoint Therapeutics, Inc. - Common Stock?
The ticker symbol for Checkpoint Therapeutics, Inc. - Common Stock is CKPT on the Nasdaq Stock Market
What is the current price of Checkpoint Therapeutics, Inc. - Common Stock?
The current price of Checkpoint Therapeutics, Inc. - Common Stock is 2.840
When was Checkpoint Therapeutics, Inc. - Common Stock last traded?
The last trade of Checkpoint Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Checkpoint Therapeutics, Inc. - Common Stock?
The market capitalization of Checkpoint Therapeutics, Inc. - Common Stock is 128.07M
How many shares of Checkpoint Therapeutics, Inc. - Common Stock are outstanding?
Checkpoint Therapeutics, Inc. - Common Stock has 45.10M shares outstanding.